Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes
- 13 July 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 190 (1) , 110-121
Abstract
One of the most widespread and effective environmental factors is the infection with enteroviruses (EVs) which accelerate β cell destruction in type 1 diabetes (T1D). This study represented a comparison between diabetic EV+ and EV– children as well as correlation analysis between autoantibodies, T1D markers, cytokines, complement activation products and anti-coxsackievirus (CV) immunoglobulin (Ig)G. EV RNA was detected in Egyptian children with T1D (26·2%) and healthy controls (0%). Detection of anti-CV IgG in T1D-EV+ resulted in 64% positivity. Within T1D-EV+, previously diagnosed (PD) showed 74 versus 56% in newly diagnosed (ND) children. Comparisons between populations showed increased levels of haemoglobin A1c (HbA1c), C-reactive protein (CRP), nitric oxide (NO), glutamic acid decarboxylase and insulin and islet cell autoantibodies [glutamic acid decarboxylase autoantibodies (GADA), insulin autoantibodies (IAA) and islet cell cytoplasmic autoantibodies (ICA), respectively], interferon (IFN)-γ, tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL −10, IL −12, IL −17, C3d and sC5–9 in T1D-EV+ versus T1D-EV–. Conversely, both IL-20 and transforming growth factor (TGF-β) decreased in T1D-EV+ versus EV–, while IL-4, −6 and −13 did not show any changes. Correlation analysis showed dependency of accelerated autoimmunity and β cell destruction on increased IFN-γ, IL-12 and IL-17 versus decreased IL-4, −6 and −13. In conclusion, IFN-γ, IL-12 and IL-17 played an essential role in exacerbating EV+-T1D, while C3d, sC5b −9, IL-10 and −20 displayed distinct patterns.Keywords
This publication has 50 references indexed in Scilit:
- In Type 1 Diabetes a Subset of Anti-Coxsackievirus B4 Antibodies Recognize Autoantigens and Induce Apoptosis of Pancreatic Beta CellsPLOS ONE, 2013
- A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitorVirology Journal, 2012
- Children With Islet Autoimmunity and Enterovirus Infection Demonstrate a Distinct Cytokine ProfileDiabetes, 2012
- Immunologic and Metabolic Biomarkers of -Cell Destruction in the Diagnosis of Type 1 DiabetesCold Spring Harbor Perspectives in Medicine, 2012
- Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell DeathDiabetes, 2011
- C-Reactive Protein Polarizes Human Macrophages to an M1 Phenotype and Inhibits Transformation to the M2 PhenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF‐β‐dependent mannerEuropean Journal of Immunology, 2009
- Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patientsProceedings of the National Academy of Sciences, 2007
- Serum IL‐1β, IL‐2, and IL‐6 in Insulin‐Dependent Diabetic ChildrenMediators of Inflammation, 2006
- Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of lifeClinical and Experimental Immunology, 2002